Adults with diabetes using an automated insulin delivery system had minimal change in time in range after switching ...

In December, online rumors hinted at the fact that Dexcom may be planning to sunset its G6 CGM sensor model. The company has now started to notify patients of the discontinuation plan. The company ...

Abbott recalled certain sensors used in its FreeStyle Libre 3 and FreeStyle Libre 3 Plus systems, warning they could produce ...

Opportunities include integrating digital health for remote care, leveraging demographic trends, and overcoming CGM unit costs to expand access across regionsDublin, March 16, 2026 (GLOBE NEWSWIRE) -- ...

Should A1c remain the gold standard for routine monitoring of glucose control in people with diabetes, or is it time to shift to “time in range” and other metrics of continuous glucose monitoring (CGM ...

In 2026, consumer wearables do more. They can flag patterns that may point to real health problems, not just a rough wellness trend.

People don't buy consumer wearables just to count steps anymore. They want early warnings, useful health signals, and features they can trust.

(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today provided a ...

At ATTD 2026, Dexcom (Nasdaq:DXCM) outlined a range of ways in which its continuous glucose monitors (CGMs) benefit people ...

As nanomaterials gain commercial traction, they have the potential to revolutionize medicine, aerospace, and 3D printing, and ...

Tandem Diabetes Care, Inc.’s TNDM impressive product launches are expected to bolster growth in the upcoming quarters. A strong solvency looks encouraging. However, concerns loom over fierce ...